Discussions Around the DeLLphi-305 Trial
Sevabertinib Moves Into First-Line HER2-Mutant NSCLC With FDA Accelerated Approval
FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer
Vanessa Kerry։ Honored to Have Been Appointed as the Director-General's Special Envoy for Health Resilience
Benjamin L. Ebert: A Major Step Forward for Personalized Cancer Vaccines
Gilberto Lopes: DeLLphi-305 Signals a Potential Shift in First-Line SCLC
Hodgkin Lymphoma in 2026: What the New EHA Guidelines Recommend
MOB-RT Supports Moderate Hypofractionated Pelvic Radiotherapy in High-Risk Prostate Cancer
The Lung Cancer 2026: Precision, Progress, and Practice conference, presented by HonorHealth and Horizon CME, will take place on November 7, 2026, at The Westin Kierland Resort & Spa in Scottsdale, Arizona. The multidisciplinary programme is designed for healthcare professionals involved across the lung cancer journey, from initial presentation and diagnosis through treatment and survivorship. […]
